GO:0070486 leukocyte aggregation: Adhesion Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070486 leukocyte aggregation is defined as the adhesion of one leukocyte to one or more other leukocytes via adhesion molecules.
• Leukocyte aggregation is a measurable cellular event in inflammation, thrombosis, hemodialysis, and cardiovascular disease.
• Platelet-leukocyte aggregates are a widely used surrogate marker of leukocyte aggregation and can be quantified by flow cytometry.
• CD147 on leukocytes mediates intrahepatic leukocyte aggregation and determines the extent of liver injury in murine models.
• Shear stress and selectin/integrin-dependent adhesion regulate platelet-leukocyte aggregation under flow.
• The leukocyte adhesiveness/aggregation test is a plasma-dependent, inflammation-related assay for leukocyte aggregation.
Description
Leukocyte aggregation (GO:0070486) is a biological process in which one leukocyte adheres to one or more other leukocytes through adhesion molecules. This process is distinct from leukocyte-endothelial adhesion and from platelet aggregation, although it frequently occurs in the context of platelet-leukocyte aggregate formation. Researchers study leukocyte aggregation because it is a sensitive cellular readout of immune activation, inflammation, and thrombotic risk. The QuickGO definition states that leukocyte aggregation is the adhesion of one leukocyte to one or more other leukocytes via adhesion molecules. Because the process is dynamic and adhesion-molecule dependent, it is commonly measured by flow cytometry, aggregometry, and imaging-based assays. In translational research, leukocyte aggregation has been linked to liver injury, cardiovascular disease, and hemodialysis-related inflammation.
leukocyte aggregation At A Glance
| GO ID | GO:0070486 |
|---|---|
| GO term | leukocyte aggregation |
| Ontology | biological_process |
| Synonym | immune cell aggregation; leucocyte aggregation; white blood cell aggregation; white corpuscle aggregation |
| Definition | The adhesion of one leukocyte to one or more other leukocytes via adhesion molecules. |
| Major function | Cell-cell adhesion of leukocytes during immune and inflammatory responses. |
| Related process | Platelet-leukocyte aggregate formation and leukocyte adhesiveness/aggregation. |
| Measured by | Flow cytometry, aggregometry, and the leukocyte adhesiveness/aggregation test. |
What Is GO:0070486?
In practical terms, leukocyte aggregation is the homotypic or heterotypic adhesion of leukocytes to one another through surface adhesion molecules. It is a cell-cell adhesion process rather than a signaling cascade, and it can be triggered by plasma factors, shear stress, and inflammatory mediators. The process is often assessed as platelet-leukocyte aggregates, in which leukocytes adhere to platelets, but the GO term itself refers specifically to leukocyte-leukocyte adhesion.
Why Is leukocyte aggregation Important in Cell Biology?
Leukocyte aggregation is important because it is an early and measurable event in inflammation and thrombosis, and it has been associated with clinical outcomes in cardiovascular disease and liver injury. Because the process depends on adhesion molecules and plasma factors, it provides a tractable experimental target for testing anti-adhesion and anti-inflammatory strategies.
• Leukocyte aggregation is a cellular hallmark of immune activation and inflammation.
• Platelet-leukocyte aggregates are prognostic markers in cardiovascular disease.
• CD147-mediated leukocyte aggregation determines the extent of liver injury in mice.
• Leukocyte aggregation occurs during hemodialysis and contributes to bioincompatibility.
• Shear stress differentially engages selectins and integrins during platelet-leukocyte aggregation.
• Combined leukocyte and erythrocyte aggregation is altered in acute myocardial infarction.
• Brain-derived gangliosides can prime platelet aggregation and induce platelet-leukocyte aggregate formation.
• The leukocyte adhesiveness/aggregation test is plasma-dependent and inflammation-related.
• Leukocyte aggregation assays are used to evaluate anti-inflammatory and anti-thrombotic drugs.
• Measuring leukocyte aggregation requires careful standardization because of its dynamic nature.
What Happens During leukocyte aggregation?
Initiation by adhesion molecule engagement
In simple terms: Leukocytes first stick to each other when adhesion molecules on their surfaces bind.
Leukocyte aggregation begins when adhesion molecules on one leukocyte engage counter-receptors on another leukocyte. This adhesion-molecule-dependent step is the defining feature of GO:0070486 and can be triggered by inflammatory mediators and plasma factors. In platelet-leukocyte aggregates, platelet adhesion molecules also participate in the initial contact.
Selectin- and integrin-dependent adhesion under flow
In simple terms: Under blood flow, selectins and integrins work together to make leukocytes clump.
Under shear stress, platelet-leukocyte aggregation involves differential contributions of selectins and integrins. Selectins mediate initial tethering, while integrins stabilize adhesion and promote aggregate formation. This mechanosensitive regulation explains why leukocyte aggregation is sensitive to flow conditions in vitro and in vivo.
Plasma-dependent agglutination
In simple terms: Blood plasma contains factors that can make leukocytes clump together.
The leukocyte adhesiveness/aggregation test is a plasma-dependent agglutination phenomenon, indicating that soluble plasma components contribute to leukocyte aggregation. This plasma dependence is relevant when interpreting aggregation assays in inflammatory diseases.
Amplification by platelet-leukocyte interactions
In simple terms: Platelets can join the cluster and make the aggregate bigger and more stable.
Platelet-leukocyte aggregate formation amplifies leukocyte aggregation and is a commonly measured endpoint in cardiovascular and inflammatory research. Brain-derived gangliosides can prime platelet aggregation and induce platelet-leukocyte aggregate formation, linking lipid mediators to this process.
Resolution and dissociation
In simple terms: Aggregates can break apart when adhesion signals fade.
Leukocyte aggregation is reversible, and dissociation depends on the loss of adhesion-molecule engagement and changes in the local milieu. Standardized measurement is therefore important to capture the dynamic range of aggregate formation and resolution.
Key Genes Involved in GO:0070486 leukocyte aggregation
The following genes and proteins have been experimentally implicated in leukocyte aggregation or in the formation of platelet-leukocyte aggregates, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD147 | Mediates intrahepatic leukocyte aggregation | Determines extent of liver injury in murine models |
| Selectins | Mediate initial tethering under shear stress | Differential involvement in platelet-leukocyte aggregation |
| Integrins | Stabilize leukocyte-leukocyte adhesion | Differential involvement under shear stress |
| Platelet adhesion molecules | Support platelet-leukocyte aggregate formation | Measured as platelet-leukocyte aggregates |
| Ganglioside-modulated platelet receptors | Prime platelet aggregation and aggregate formation | Brain-derived gangliosides induce platelet-leukocyte aggregates |
| Plasma agglutinating factors | Promote plasma-dependent leukocyte aggregation | Leukocyte adhesiveness/aggregation test |
| Leukocyte adhesion receptors | Engage counter-receptors on other leukocytes | Defining feature of GO:0070486 |
| Erythrocyte aggregation-related factors | Contribute to combined aggregation in myocardial infarction | Combined leukocyte and erythrocyte aggregation |
| Hemodialysis-responsive adhesion molecules | Mediate platelet-leukocyte aggregation during hemodialysis | Bioincompatibility research |
| Inflammation-related plasma proteins | Modulate leukocyte adhesiveness | Inflammation-related agglutination |
| Cardiovascular risk-associated adhesion molecules | Link aggregation to prognosis | Prognostic significance in cardiovascular disease |
| Shear-responsive adhesion complexes | Adapt adhesion to flow | Shear stress studies |
| Platelet P-selectin-related pathways | Support platelet-leukocyte contact | Platelet-leukocyte aggregate measurement |
| Leukocyte beta2 integrin-related pathways | Stabilize aggregates | Integrin involvement under shear |
| CD147-associated extracellular matrix proteins | Modulate intrahepatic aggregation | Liver injury models |
How Is leukocyte aggregation Regulated?
Leukocyte aggregation is regulated by adhesion-molecule expression and activation, plasma factors, and mechanical forces such as shear stress. Selectins and integrins differentially regulate platelet-leukocyte aggregation under flow, indicating that the process is not a single linear pathway but a coordinated adhesion response. Plasma-dependent agglutination further shows that soluble mediators can modulate leukocyte aggregation independently of direct cell-cell contact. In disease settings such as hemodialysis and acute myocardial infarction, systemic activation of platelets and leukocytes shifts the balance toward aggregate formation.
leukocyte aggregation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD147 | Liver injury | Knockout or knock-in mouse models of hepatic leukocyte aggregation |
| Selectins | Thrombosis and inflammation | Point-mutation or knockout models under shear stress |
| Integrins | Platelet-leukocyte aggregation | Knockout or overexpression cell models under flow |
| Platelet adhesion molecules | Cardiovascular disease | Platelet-leukocyte aggregate assays in whole blood |
| Plasma agglutinating factors | Systemic inflammation | Plasma-dependent leukocyte adhesiveness/aggregation test |
Liver injury and CD147-mediated leukocyte aggregation
CD147 mediates intrahepatic leukocyte aggregation and determines the extent of liver injury in murine models. This links leukocyte aggregation directly to tissue damage and suggests that adhesion-molecule blockade could modify liver injury outcomes.
Cardiovascular disease and platelet-leukocyte aggregates
Platelet-leukocyte aggregates have prognostic significance in cardiovascular disease and are considered a therapeutic target. Combined leukocyte and erythrocyte aggregation is altered in patients with acute myocardial infarction, supporting a role for aggregation in atherothrombotic events.
Hemodialysis-associated inflammation
Platelet-leukocyte aggregation occurs during hemodialysis and reflects blood-biomaterial interaction. Measuring these aggregates can help evaluate the inflammatory response to dialysis membranes.
Inflammation and plasma-dependent agglutination
The leukocyte adhesiveness/aggregation test is an inflammation-related, plasma-dependent agglutination phenomenon. This assay has been used to study systemic inflammatory states and provides a simple readout of leukocyte aggregation.
From leukocyte aggregation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CD147 mediate leukocyte aggregation in liver injury? | CD147 knockout or knock-in mouse models |
| How do selectins and integrins differentially regulate aggregation under shear? | Point-mutation or knockout endothelial/leukocyte co-culture under flow |
| Can platelet-leukocyte aggregate formation be blocked therapeutically? | Overexpression or knockout models combined with flow cytometry |
| What plasma factors drive leukocyte agglutination? | Plasma-dependent leukocyte adhesiveness/aggregation test |
| Does hemodialysis alter platelet-leukocyte aggregation? | Ex vivo whole-blood aggregation assays during dialysis |
| Are gangliosides sufficient to induce platelet-leukocyte aggregates? | Knock-in or overexpression models of ganglioside-modulated pathways |
How to Study the leukocyte aggregation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Platelet-leukocyte aggregates | Cardiovascular and inflammation studies |
| Leukocyte adhesiveness/aggregation test | Plasma-dependent leukocyte aggregation | Systemic inflammation assessment |
| Microfluidic shear assays | Selectin/integrin-dependent adhesion | Mechanistic studies under flow |
| Intravital imaging | Intrahepatic leukocyte aggregation | Liver injury models |
| Aggregometry | Platelet and leukocyte aggregation | Hemodialysis and cardiovascular research |
| Immunophenotyping | Adhesion molecule expression | Leukocyte subset analysis |
| Whole-blood aggregation assays | Ex vivo aggregate formation | Clinical and translational studies |
Flow cytometry for platelet-leukocyte aggregates
Flow cytometry is a standard method to measure and interpret platelet-leukocyte aggregates, allowing identification of leukocyte subsets and platelet markers. It is widely used in cardiovascular and inflammatory studies.
Leukocyte adhesiveness/aggregation test
The leukocyte adhesiveness/aggregation test measures plasma-dependent agglutination and is an inflammation-related assay. It provides a simple readout of leukocyte aggregation in clinical samples.
Shear stress and microfluidic assays
Shear stress assays reveal differential involvement of selectins and integrins in platelet-leukocyte aggregation. These methods are useful for studying mechanosensitive adhesion in vitro.
In vivo imaging of intrahepatic leukocyte aggregation
Intravital imaging and histology can assess CD147-mediated intrahepatic leukocyte aggregation and its relationship to liver injury. Such models link aggregation to tissue-level outcomes.
How CRISPR Can Be Used to Study GO:0070486 leukocyte aggregation
Knockout
CRISPR knockout of adhesion molecules such as CD147, selectins, or integrins can test whether they are required for leukocyte aggregation in cell and animal models. Knockout models are useful for establishing causality in liver injury and thrombosis research.
Point Mutation
Point mutations can be introduced into adhesion molecule domains to dissect selectin- versus integrin-dependent aggregation under shear stress. Such models help identify the specific residues that mediate leukocyte-leukocyte adhesion.
Knock-in
Knock-in of tagged or humanized adhesion molecules allows tracking of leukocyte aggregation in vivo and in vitro. Tagged knock-in models can be combined with flow cytometry to quantify aggregate formation.
Overexpression
Overexpression of CD147 or platelet adhesion molecules can drive leukocyte aggregation and platelet-leukocyte aggregate formation in otherwise low-aggregation systems. Overexpression models are useful for testing whether a candidate gene is sufficient to induce aggregation.
How EDITGENE Supports leukocyte aggregation Research
Researchers studying leukocyte aggregation-related genes often need to determine whether a candidate gene is causally involved in leukocyte-leukocyte adhesion or platelet-leukocyte aggregate formation. EDITGENE provides CRISPR-based cell and animal models to test these hypotheses with defined genetic perturbations.
Contact EDITGENE today to design your custom CRISPR model for leukocyte aggregation research.
Frequently Asked Questions About leukocyte aggregation
What is leukocyte aggregation?
Leukocyte aggregation is the adhesion of one leukocyte to one or more other leukocytes via adhesion molecules, defined as GO:0070486.
What genes are involved in leukocyte aggregation?
Genes implicated in leukocyte aggregation include CD147, selectins, and integrins, based on experimental studies.
How is leukocyte aggregation measured?
It is measured by flow cytometry, aggregometry, and the leukocyte adhesiveness/aggregation test.
What are platelet-leukocyte aggregates?
Platelet-leukocyte aggregates are complexes of platelets and leukocytes that form during aggregation and are used as a marker of leukocyte aggregation.
Is leukocyte aggregation the same as platelet aggregation?
No, leukocyte aggregation refers to leukocyte-leukocyte adhesion, while platelet aggregation refers to platelet-platelet adhesion, although they can occur together.
What diseases are associated with leukocyte aggregation?
Leukocyte aggregation has been associated with liver injury, cardiovascular disease, hemodialysis-related inflammation, and acute myocardial infarction.
Does shear stress affect leukocyte aggregation?
Yes, shear stress differentially engages selectins and integrins during platelet-leukocyte aggregation.
What is the leukocyte adhesiveness/aggregation test?
It is a plasma-dependent, inflammation-related agglutination assay for leukocyte aggregation.
Can leukocyte aggregation be studied with CRISPR?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to study genes involved in leukocyte aggregation.
Why is leukocyte aggregation important in cardiovascular disease?
Platelet-leukocyte aggregates have prognostic significance in cardiovascular disease and are considered a therapeutic target.
Conclusion
Leukocyte aggregation (GO:0070486) is a defined biological process of leukocyte-leukocyte adhesion via adhesion molecules, with measurable roles in inflammation, thrombosis, liver injury, and cardiovascular disease. Standardized assays such as flow cytometry and the leukocyte adhesiveness/aggregation test enable reproducible study of this process. CRISPR-based models provide a direct way to test the causal contribution of specific adhesion molecules to leukocyte aggregation.
References
- 1. Yee C et al.. 2019. CD147 mediates intrahepatic leukocyte aggregation and determines the extent of liver injury.. PLoS One 14(7):e0215557 PMID: 31291257
- 2. Noro F et al.. 2024. Brain-derived gangliosides prime human platelet aggregation and induce platelet-leukocyte aggregate formation.. J Thromb Haemost 22(11):3221-3234 PMID: 39122190
- 3. Finsterbusch M et al.. 2018. Measuring and interpreting platelet-leukocyte aggregates.. Platelets 29(7):677-685 PMID: 29461910
- 4. Gawaz MP et al.. 1994. Platelet-leukocyte aggregation during hemodialysis.. Kidney Int 46(2):489-95 PMID: 7526025
- 5. Hu H et al.. 2003. Platelet-leukocyte aggregation under shear stress: differential involvement of selectins and integrins.. Thromb Haemost 90(4):679-87 PMID: 14515189
- 6. Shapira I et al.. 2001. Combined leukocyte and erythrocyte aggregation in patients with acute myocardial infarction.. Int J Cardiol 78(3):299-305 PMID: 11376834
- 7. Han J et al.. 2025. Platelet-leukocyte aggregates in cardiovascular disease: prognostic significance and therapeutic potential.. Cardiovasc Res 121(11):1679-1696 PMID: 40488451
- 8. Zeltser D et al.. 1998. The leukocyte adhesiveness/aggregation test as an inflammation-related, plasma-dependent agglutination phenomenon.. Scand J Clin Lab Invest 58(7):593-601 PMID: 9890343
